Idi Sca Stock Quote 0I0P - Stock Price, News, Charts, Message Board, Trades

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
UK
LSE
Idi Sca (0I0P) Quote

Idi Sca (0I0P)

50.00

0.00

(0.00%)

Closed January 05 11:30AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

50.00

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

50.00 52 Week Range 50.00

Market Cap

Previous Close

50.00

Open

-

Last Trade

Last Trade Time

Financial Volume

-

VWAP

-

Average Volume (3m)

16

Shares Outstanding

7,188,000

Dividend Yield

-

PE Ratio

6.92

Earnings Per Share (EPS)

9.85

Revenue

6.11M

Net Profit

70.81M

Sector

Offices-holdng Companies,nec

Industry

Offices-holdng Companies,nec

Website

www.idi.fr/fr

Headquarters

Paris, Paris, Fra

Founded

-

Idi Sca is listed in the Offices-holdng Companies sector of the London Stock Exchange with ticker 0I0P. The last closing price for Idi Sca was 50.00 €. Over the last year, Idi Sca shares have traded in a share price range of 50.00 € to 50.00 €.

Idi Sca currently has 7,188,000 shares outstanding. The market capitalization of Idi Sca is 359.40 € million. Idi Sca has a price to earnings ratio (PE ratio) of 6.92.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	50	50	50	0	0	DE
4	0	0	50	50	50	26	50	DE
12	0	0	50	50	50	16	50	DE
26	0	0	50	50	50	25	50	DE
52	0	0	50	50	50	20	50	DE
156	0	0	50	50	50	88	50	DE
260	0	0	50	50	50	53	50	DE

0I0P - Frequently Asked Questions (FAQ)

What is the current Idi Sca share price?

The current share price of Idi Sca is 50.00 €

How many Idi Sca shares are in issue?

Idi Sca has 7,188,000 shares in issue

What is the market cap of Idi Sca?

The market capitalisation of Idi Sca is EUR 359.4M

What is the 1 year trading range for Idi Sca share price?

Idi Sca has traded in the range of 50.00 € to 50.00 € during the past year

What is the PE ratio of Idi Sca?

The price to earnings ratio of Idi Sca is 6.92

What is the cash to sales ratio of Idi Sca?

The cash to sales ratio of Idi Sca is 80.21

What is the reporting currency for Idi Sca?

Idi Sca reports financial results in EUR

What is the latest annual turnover for Idi Sca?

The latest annual turnover of Idi Sca is EUR 6.11M

What is the latest annual profit for Idi Sca?

The latest annual profit of Idi Sca is EUR 70.81M

What is the registered address of Idi Sca?

The registered address for Idi Sca is 23-25 AVENUE FRANKLIN D. ROOSEVELT, PARIS, PARIS, 75008

What is the Idi Sca website address?

The website address for Idi Sca is www.idi.fr/fr

Which industry sector does Idi Sca operate in?

Idi Sca operates in the OFFICES-HOLDNG COMPANIES,NEC sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCFTheracryf Plc	0.725p (38.10%)	7.56M
NMTNeometals Ltd	3.50p (27.27%)	346.81k
SCHOScholium Group Plc	44.00p (25.71%)	30.65k
FABFusion Antibodies Plc	10.15p (24.54%)	3.34M
PYXPyx Resources Limited	3.49p (22.24%)	8.43k
TM1Technology Minerals Plc	0.125p (-24.24%)	37.21M
QUIZQuiz Plc	0.70p (-18.60%)	3.67M
SYMESupply@me Capital Plc	0.003p (-17.81%)	168.35M
OBDOxford Biodynamics Plc	1.20p (-14.29%)	827.83k
ZENZenith Energy Ltd.	5.25p (-13.93%)	5.39M
TRPTower Resources Plc	0.0395p (5.33%)	539.51M
CPXCap-xx Limited	0.1825p (1.39%)	494M
NTVONativo Resources Plc	0.0019p (0.00%)	320.16M
DGIDg Innovate Plc	0.0225p (-13.46%)	208.21M
ENETEthernity Networks Ltd	0.1125p (2.27%)	207.56M

WeTheMarket

WeTheMarket 54 seconds ago

Posted 3 days ago.

https://www.youtube.com/live/7NdcbYzNVyM?si=6d0W8g88o2V1bBX9

real777mellon

real777mellon 2 minutes ago

https://x.com/RadarHits/status/1830202479490834769

Political is not a word I use. Targeted. From here out - Targeted is allowed.

So is detailed court fallout in this NEW incoming administration. It's called POLICY changes.

No more personal attacks. As fo

georgejjl

georgejjl 2 minutes ago

Now many catalysts are in progress???

Alzheimer’s disease: Data from the blarcamesine Phase 2b/3 ANAVEX®2-73-AD-004 trial to be published in an upcoming peer-reviewed journal to be published SOON in the JPAD peer reviewed journal

Alzheimer’s disease: Full regulatory

jimr1717

jimr1717 2 minutes ago

ATMH DD>> 🏆️

Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobile Analy

OMOLIVES

OMOLIVES 2 minutes ago

I can't believe we were born in the same hospital. I don't think anyone here can even comprehend how rare this is given where it was...lol. The current population there is less than 3400 lol...lol.

In 1940...it was less than 6500. That is mind boggling and crazy cool.

BDEZ

BDEZ 2 minutes ago

No mas Trudeau, he quit.

Retire43

Retire43 3 minutes ago

For all of you, Pharma tech people out there read this:

joe botts

joe botts 4 minutes ago

Not much downside left , we are 1 tick from no bid.

Vexari

Vexari 4 minutes ago

Interesting

To say the least

Dive bomber

In and out

Ecomike

Ecomike 5 minutes ago

Just watch my Sunday morning news programs. Seems bird flu is huge problem and Biden administration is stockpiling vaccines. Did I understand correctly Bioxy has something drug for this?

Yes you did. It is 100% non toxic, oral pill, safe for Humans, not a vaccine, but a 100% c

Eli's Gone

Eli's Gone 5 minutes ago

Wasn't much fun today for the Bengals watching the Chiefs lay down and get bageled by Denver with Cincy's playoff fate on the line----I know, I know it was Cincy's fault that they were in that position---but still

flipper44

flipper44 5 minutes ago

flipper44

flipper44 5 minutes ago

Really hoping LP rips shorts and other manipulators a new one. Have a good evening.

JRoon71

JRoon71 7 minutes ago

Thanks Lizzy. I've been following MS's holdings closely the past few years, especially in relationship to Sarissa's reported holdings. Match them up and it is rather informative.

Louis Sterling is the board member trading significant volume of options, beginning in early 2021.

nowwhat2

nowwhat2 8 minutes ago

The Diamond Of Destiny...................BEFORE it all happened

https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

https://investorshub.advfn.com/uimage/uploads/2025/1/5/pzgv[TOTAL_3_!_4_5d_JUNCT_DAY_1.jpg

flipper44

flipper44 8 minutes ago

Jackxkr

Jackxkr 9 minutes ago

Foolish to sell at a buck if they get approval. You are saying that a cancer cure /treatment is on ly worth 1.5 billiin with nothing valued on potential.

ddls

ddls 9 minutes ago

Pumping up the rhetoric pre-open are we? Classic!😎

The Great Pumpkin

The Great Pumpkin 9 minutes ago

Sorry but you’ve continuously been WRONG here for decades and have ZERO credibility. I trust my knowledge and sources over your frantic pumping and conjecture. You seem worried…

#scam

EZBoss

EZBoss 10 minutes ago

Hi $DUTV Team - Things on the business side of $DUTV are going well. The next 45 days are going to be very busy. We are attending 5 different customer trade shows. We are kicking

mrMadMax

mrMadMax 10 minutes ago

"But of course, dd 96, these🤡 two characters continue to write the opposite of what they really think, so believe me, nobody takes them seriously. They are two fish out of water... or rather, two fools who no longer have any meaning."

real777mellon

real777mellon 10 minutes ago

What the hell are you talking about. TARGETED- LEHMAN WAS TARGETED:
https://x.com/RadarHits/status/1830202479490834769

Knock it off. I'm not taking personal attacks because you want to fight and label

Clark6290

Clark6290 11 minutes ago

Yeah, but Aircase may live in fantasy land. Wishful, but didn't post any facts

OMOLIVES

OMOLIVES 12 minutes ago

Sure..and I know a lot about pancreatic cancer on a personal level. It's a death sentence. Even if operable..and that is usually not often...you get maybe five years max. If it could extend a non operable patient and give them five years...great. Better than the usual one year of life-median.

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions